Vardenafil (Levitra/Staxyn) Food and Supplement Interactions

How Vardenafil Works: The Mechanism Behind the Drug

Vardenafil blocks PDE5, the enzyme that degrades cyclic GMP in penile smooth muscle. Blocking PDE5 lets cyclic GMP accumulate, smooth muscle relaxes, arterial inflow increases, and an erection follows. The drug does not create an erection on its own. Sexual stimulation must trigger the upstream nitric-oxide release that starts this cascade.

PDE5 Selectivity and Why It Matters for Interactions

Vardenafil is roughly ten times more selective for PDE5 over PDE6 than sildenafil, which translates into fewer visual disturbances at therapeutic doses. Its selectivity over PDE1 (found in cardiac and vascular smooth muscle) is also meaningful: PDE1 inhibition contributes to the blood-pressure effects seen when the drug combines with vasodilators or certain supplements. The FDA-approved prescribing information notes that vardenafil inhibits PDE5 with an IC50 of 0.7 nM. [1]

Pharmacokinetics That Drive Food Interactions

Vardenafil is absorbed via the gut, reaches peak plasma concentration (Tmax) in 30 to 120 minutes under fasted conditions, and is metabolized primarily by hepatic CYP3A4, with minor contributions from CYP3A5 and CYP2C9. [2] Its half-life is 4 to 5 hours. Because CYP3A4 handles the bulk of clearance, any food or supplement that inhibits this enzyme will raise vardenafil blood levels, and any inducer will lower them.

The High-Fat Meal Problem

A high-fat meal reduces vardenafil's peak plasma concentration (Cmax) by approximately 18 to 20 percent and pushes Tmax from around 60 minutes to roughly 120 minutes. [1] In practical terms, a man who takes 10 mg after a fatty steak dinner may find the drug under-performing in the first hour, then hitting harder when he least expects it.

What Counts as "High Fat"

The FDA defines a high-fat test meal at about 800 to 1,000 calories with 50 percent of calories from fat. A double cheeseburger with fries fits this threshold. A chicken salad with olive oil dressing probably does not, though no clinical trial has tested every meal composition.

Low-Fat Meals: Acceptable Timing

Low-fat and moderate-fat meals do not meaningfully alter vardenafil pharmacokinetics in the package-label data. [1] If a patient wants to time the drug reliably, taking it with a light meal (or fasted, if tolerated) and targeting the 60-minute mark before activity is the most predictable approach.

Practical Dosing Instruction

The prescribing information recommends taking vardenafil without regard to food for most patients, but that language assumes moderate meal fat content. Patients eating a high-fat restaurant meal should add 30 to 45 minutes to their usual timing window rather than increasing the dose.

Grapefruit and Grapefruit Juice

Grapefruit juice contains furanocoumarins, particularly bergamottin and 6',7'-dihydroxybergamottin, that irreversibly inhibit intestinal CYP3A4. [3] With CYP3A4 partially blocked, vardenafil bypasses first-pass metabolism more completely, raising systemic AUC in a dose-dependent and individual-variable way.

Magnitude of the Interaction

No large randomized trial has quantified the exact AUC increase for vardenafil plus grapefruit specifically, but parallel data from other CYP3A4-cleared drugs (e.g., the CYP3A4-inhibitor ketoconazole 200 mg raises vardenafil AUC approximately 10-fold) indicate the enzyme is a high-use target. [1] Even a single 8-ounce glass of grapefruit juice can suppress intestinal CYP3A4 for 24 to 72 hours. [3] The unpredictability, not just the magnitude, is the clinical hazard.

Seville Oranges and Pomelos

Seville oranges (common in marmalades) and pomelos contain the same furanocoumarins. Regular navel and Valencia oranges do not. Patients should avoid Seville orange marmalade on the morning of a vardenafil dose, though this is rarely counseled.

Alcohol: Where the Line Is

Two standard drinks (24 g ethanol, approximately two 12-oz beers or two 5-oz glasses of wine) appear to be a reasonable upper threshold based on interaction studies included in the vardenafil NDA package. [1] Both ethanol and vardenafil cause peripheral vasodilation. Their combination is additive, not merely synergistic, for blood-pressure lowering.

The Orthostatic Hypotension Risk

Alcohol-induced vasodilation concentrates in the splanchnic and cutaneous beds. Vardenafil-induced vasodilation is more generalized. Together, the two agents increase the probability of orthostatic hypotension, presenting as dizziness on standing or, in older patients, falls. A 2002 pharmacodynamic study found that 0.5 g/kg ethanol combined with sildenafil (a pharmacologically similar PDE5 inhibitor) did not produce clinically meaningful additional hemodynamic changes, but that study used a controlled alcohol dose well below heavy-drinking thresholds. [4]

Three or More Drinks: Avoid

Beyond two standard drinks, the combination carries an unpredictable hypotension risk. This is especially true for men over 65, those on alpha-blockers (e.g., tamsulosin 0.4 mg), or patients with baseline low blood pressure. The prescribing information for vardenafil states that concomitant administration with alpha-blockers requires caution and a 6-hour separation for certain agents. [1]

Nitrates: The Absolute Contraindication

This section is brief because the answer is binary. Vardenafil is absolutely contraindicated with all organic nitrates and nitric-oxide donors. [1] The combination produces severe, potentially fatal hypotension. There is no safe interval or dose adjustment that removes this risk.

Drugs in this category include nitroglycerin (sublingual, transdermal, IV), isosorbide mononitrate, isosorbide dinitrate, amyl nitrite, and recreational "poppers" (amyl or butyl nitrite). Any patient on scheduled or PRN nitrates cannot use vardenafil.

Supplement Interactions: The Under-Counseled Risk

Most prescribing conversations focus on nitrates and grapefruit. Supplement interactions get less attention despite being clinically meaningful. The global supplement market exceeded $150 billion USD in 2022, and the percentage of men using supplements who also take PDE5 inhibitors is not trivial. [5]

L-Arginine

L-arginine is an amino acid substrate for nitric oxide synthase (NOS). Supplemental L-arginine, especially at doses above 3 g per day, can increase circulating nitric oxide and cause vasodilation. In combination with vardenafil, which is already amplifying the cyclic-GMP downstream signal, the additive vasodilation may produce symptomatic hypotension.

A 2019 Cochrane review of oral L-arginine for erectile dysfunction (N=574, 10 trials) found that L-arginine at doses of 1.5 to 5 g daily showed modest efficacy over placebo, but the review explicitly flagged blood-pressure interactions when combined with PDE5 inhibitors as an unresolved safety question. [6] Patients combining L-arginine with vardenafil should start at the lower 5 mg vardenafil dose and monitor standing blood pressure.

Yohimbine and Yohimbe Bark

Yohimbine is an alpha-2 adrenergic antagonist derived from the bark of Pausinystalia yohimbe. It is sold widely as a fat-burner and libido supplement. Alpha-2 blockade raises norepinephrine release, producing stimulant-like cardiovascular effects: increased heart rate and blood pressure at moderate doses, but paradoxical hypotension and reflex tachycardia at higher doses. [7]

Combining yohimbine with vardenafil creates competing hemodynamic signals that are difficult to predict. The net blood pressure effect depends on dose, timing, and the individual's baseline autonomic tone. Men with hypertension, arrhythmia, or anxiety disorders should avoid yohimbine entirely when taking any PDE5 inhibitor.

St. John's Wort (Hypericum perforatum)

St. John's Wort is a potent CYP3A4 inducer and P-glycoprotein inducer. Chronic use (the typical pattern for mood support) can reduce vardenafil AUC by a clinically significant margin. In a well-characterized study, St. John's Wort reduced the AUC of CYP3A4-cleared drugs by 40 to 70 percent. [8] A man taking St. John's Wort who finds vardenafil "not working" may in fact have sub-therapeutic drug levels. The solution is not increasing the dose; it is stopping the supplement (with physician guidance) and allowing CYP3A4 to normalize over 2 weeks.

Saw Palmetto

Saw palmetto (Serenoa repens) is taken widely for lower urinary tract symptoms and benign prostatic hyperplasia. No strong pharmacokinetic interaction data exist for saw palmetto plus vardenafil specifically. Saw palmetto has weak 5-alpha-reductase activity and some anti-androgenic effects, but it does not appear to significantly affect CYP3A4. [9] The indirect concern is additive alpha-1 adrenergic activity: saw palmetto extracts may have mild alpha-1 antagonist properties, which could modestly lower blood pressure in a direction consistent with vardenafil's effects. The risk is low but worth noting in men already on alpha-blockers.

Panax Ginseng (Red Ginseng)

A 2008 systematic review of red ginseng for erectile dysfunction (N=119 across 6 trials) found modest pro-erectile effects, likely mediated by nitric-oxide pathway facilitation. [10] This overlapping mechanism means that panax ginseng, like L-arginine, theoretically compounds vardenafil's vasodilatory action. Clinical reports of harm are sparse, but patients using high-dose ginseng (above 3 g per day) should be advised to start vardenafil at 5 mg.

Zinc and Magnesium Supplements

Zinc deficiency is associated with testosterone deficiency, and some men supplement zinc to address low libido. There is no known pharmacokinetic interaction between zinc or magnesium and vardenafil. These minerals do not affect CYP3A4 in any meaningful way and are generally safe to use concurrently, at standard supplemental doses.

DHEA

DHEA (dehydroepiandrosterone) is converted to androgens and estrogens peripherally. It has mild vasoactive properties, but at typical supplemental doses (25 to 50 mg per day) there is no documented PK interaction with vardenafil. [11] Men taking DHEA for testosterone support may combine it with vardenafil without dose adjustment, though a physician should confirm baseline hormone levels before starting either agent.

Drug Interactions That Compound Food and Supplement Risks

Understanding the CYP3A4 inhibitor/inducer axis helps clinicians predict novel interactions before case reports accumulate. The following framework organizes co-administered agents by their effect on vardenafil exposure:

Agents that INCREASE vardenafil exposure (require dose reduction to 5 mg max or avoidance):

• Ketoconazole 200 mg: raises vardenafil AUC ~10-fold [1]
• Ritonavir: raises vardenafil AUC ~49-fold; vardenafil is contraindicated with ritonavir [1]
• Clarithromycin, itraconazole: strong CYP3A4 inhibitors; use 5 mg maximum
• Grapefruit juice (any amount): avoid entirely due to variability

Agents that DECREASE vardenafil exposure (risk of treatment failure):

• St. John's Wort: 40 to 70 percent AUC reduction [8]
• Rifampin: potent CYP3A4 inducer; may render standard doses ineffective
• Carbamazepine, phenytoin, phenobarbital: moderate inducers; monitor for reduced efficacy

Additive hypotension without PK interaction:

• Alpha-blockers (tamsulosin, doxazosin): pharmacodynamic interaction; requires 6-hour separation
• Antihypertensives (amlodipine, lisinopril): additive blood-pressure lowering; use 5 mg starting dose
• L-arginine, yohimbine (at high doses): see supplement section above

The Diabetic Patient: Special Considerations from Porst et al.

Porst et al. (Int J Impot Res, 2003, N=452 diabetic men with ED) demonstrated that vardenafil 10 mg and 20 mg produced significantly greater improvement in International Index of Erectile Function (IIEF) scores compared to placebo over 12 weeks: the 20 mg group achieved a mean IIEF erectile function domain score of 16.4 versus 10.6 for placebo (P<0.001). [12] This trial is particularly relevant to food and supplement interactions because diabetic men often take multiple medications and supplements simultaneously.

Diabetic patients commonly use:

• Alpha-lipoic acid (antioxidant for neuropathy): no known CYP3A4 interaction, low risk
• Berberine (blood glucose support): mild CYP3A4 inhibition possible at doses above 1 g per day; monitor
• Chromium picolinate: no known interaction with vardenafil
• Metformin: no PD or PK interaction with vardenafil; safe combination

The Porst trial used standard dosing without dietary restrictions, which reflects real-world conditions. Diabetic men with gastroparesis or delayed gastric emptying may experience even slower and more variable vardenafil absorption after any meal. Fasting administration or low-fat snacks are preferable for this population.

Orodispersible Staxyn vs. Standard Levitra Tablet: Does Food Interaction Differ?

Staxyn is a 10 mg orodispersible tablet (ODT) that dissolves under the tongue. Its bioavailability is higher than the standard film-coated Levitra tablet. The prescribing information for Staxyn states it should not be taken with any liquid (including water) within the first few minutes of administration. [13]

Because the ODT bypasses first-pass intestinal absorption more extensively (buccal and sublingual absorption partially circumvents gut CYP3A4), the food interaction profile is somewhat different. High-fat meals are less likely to delay absorption via the intestinal route when the buccal route predominates, but grapefruit juice remains relevant for hepatic CYP3A4 metabolism. Staxyn should not be substituted for Levitra on a milligram-for-milligram basis with standard tablets because the bioavailability is not identical.

Clinical Counseling Summary: What to Tell Patients

Every clinician prescribing vardenafil should cover five concrete points before the patient leaves:

1. Take the drug 60 minutes before activity on a light meal or fasted stomach. Add 30 to 45 minutes if eating a high-fat meal.
2. Avoid grapefruit juice and Seville orange products for at least 24 hours before each dose.
3. Limit alcohol to two standard drinks maximum on the day of use.
4. Stop yohimbine and St. John's Wort before starting vardenafil. Discuss L-arginine doses above 3 g daily with the prescribing physician.
5. Report any new supplement or herbal product at every follow-up. CYP3A4 inhibitors in supplements can double or triple drug exposure without any change in the prescription.

Patients who report "Levitra stopped working" after a stable response should be asked specifically about new supplement use before the dose is escalated. A man who added a pre-workout containing yohimbine and then started St. John's Wort for mood would experience two opposing effects simultaneously, creating an unpredictable clinical picture.

The standard 10 mg starting dose recommended in the Levitra prescribing information remains appropriate for most men ages 18 to 64 with no hepatic impairment and no strong CYP3A4 interactors. [1] Men over 65 should start at 5 mg regardless of supplement use.